Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy

scientific article published on 01 January 1997

Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0387-7604(96)00056-3
P698PubMed publication ID9071488

P2093author name stringM Kobayashi
T Yamamoto
K Saito
E Kondo
M Osawa
C Toyoda
P2860cites workLocalization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33Q28257920
Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetusQ28291726
Neuronal migration, with special reference to developing human brain: a reviewQ39880021
Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.Q40792342
Destruction of meningeal cells over the newborn hamster cerebellum with 6-hydroxydopamine prevents foliation and lamination in the rostral cerebellumQ41245657
Abnormal localization of laminin subunits in muscular dystrophiesQ42503064
Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD).Q42517399
Meningeal cells are involved in foliation, lamination, and neurogenesis of the cerebellum: evidence from 6-hydroxydopamine-induced destruction of meningeal cellsQ42527917
Congenital muscular dystrophy as a disease of the central nervous systemQ48379271
Meningeal cells influence cerebellar development over a critical periodQ48411302
Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type).Q48647852
Prenatal diagnosis of Fukuyama type congenital muscular dystrophy by polymorphism analysisQ48830604
Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerationsQ70859118
Marginal glioneural heterotopias of the central nervous systemQ72659453
P433issue1
P921main subjectFukuyama congenital muscular dystrophyQ1955377
P304page(s)35-42
P577publication date1997-01-01
P1433published inBrain and DevelopmentQ15750896
P1476titlePial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy
P478volume19

Reverse relations

cites work (P2860)
Q29347528A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss.
Q36810193Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy
Q30942094Cerebellar cortical dysplasia: MRI aspects and significance
Q43542175Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy
Q43818931Deficiency of a 180-kDa extracellular matrix protein in Fukuyama type congenital muscular dystrophy skeletal muscle
Q50465175Developmental changes of mast cell populations in the cerebral meninges of the rat.
Q48393339Essential role of alpha 6 integrins in cortical and retinal lamination
Q42479480Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane
Q48277389Immature astrocytes in Fukuyama congenital muscular dystrophy: an immunohistochemical study
Q48224285Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study
Q41854949Roles of fukutin, the gene responsible for fukuyama-type congenital muscular dystrophy, in neurons: possible involvement in synaptic function and neuronal migration
Q28139770The Fukuyama congenital muscular dystrophy story
Q48867792The role of Glial-Pial barrier lesions and impaired vascularization in anomalous formation of cortical convolutions
Q60300741The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy
Q52036416[MR imaging in mental retardation]

Search more.